Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Update
Clearmind Medicine Inc. (NASDAQ:CMND – Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 341,200 shares, a growth of 151.8% from the May 31st total of 135,500 shares. Based on an average daily volume of 1,240,000 shares, […]
More Stories
REGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Rating of “Moderate Buy” by Analysts
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings...
Transocean (NYSE:RIG) PT Raised to $6.00 at Morgan Stanley
Transocean (NYSE:RIG – Get Free Report) had its price target increased by stock analysts at Morgan Stanley from $5.00 to...
Devon Energy (NYSE:DVN) Coverage Initiated at Jefferies Financial Group
Equities research analysts at Jefferies Financial Group started coverage on shares of Devon Energy (NYSE:DVN – Get Free Report) in...
Bank OZK (NASDAQ:OZKAP) Announces Quarterly Dividend of $0.29
Bank OZK (NASDAQ:OZKAP – Get Free Report) declared a quarterly dividend on Thursday, October 3rd, Wall Street Journal reports. Stockholders...
AngioDynamics (NASDAQ:ANGO) Issues FY 2025 Earnings Guidance
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of...
RTX (NYSE:RTX) Rating Increased to Hold at Deutsche Bank Aktiengesellschaft
RTX (NYSE:RTX – Get Free Report) was upgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a “sell” rating to...